The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours

Background: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hande Süer Mickler, Murat Mert Erkan
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/24/2841
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850049433318719488
author Hande Süer Mickler
Murat Mert Erkan
author_facet Hande Süer Mickler
Murat Mert Erkan
author_sort Hande Süer Mickler
collection DOAJ
description Background: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- Tyr3-octreotate (DOTATATE) has been employed for SSTR targeting for either diagnostic or therapeutic purposes depending on the labelling with <sup>68</sup>Gallium or <sup>177</sup>Lutetium, respectively. SSTR expression is reported in a subset of breast adenocarcinoma and breast neuroendocrine carcinomas; however, minimal knowledge exists regarding their expression in fibroepithelial (biphasic) breast lesions such as fibroadenoma and phyllodes tumours. Aggressive ends of the spectrum, i.e., “cystosarcoma phyllodes”, may present a management challenge with recurrences and metastases, and SSTRs could be a promising therapeutic target for these types of tumours. Methods: Gene and protein expressions of SSTRs in primary human fibroepithelial lesions of the breast are investigated using RT-PCR and immunoblotting. Localisation of the SSTR-positive cells was determined with immunohistochemistry and immunofluorescence. Results and Conclusions: Both fibroadenoma and phyllodes tumours express SSTRs. Immunohistochemical analyses suggested that this expression is in the stromal, not epithelial, component by demonstrating that SSTR stained in the areas overlapping with α-smooth muscle actin-positive myoepithelial cells around blood vessels and capillary structures. This study is the first in the literature to demonstrate SSTR positivity in mammary fibroepithelial neoplasms. Once validated, these findings may also have significant implications for managing the treatment of these tumours.
format Article
id doaj-art-332f2d3a309f434ebf0ff8fd96ca432c
institution DOAJ
issn 2075-4418
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-332f2d3a309f434ebf0ff8fd96ca432c2025-08-20T02:53:43ZengMDPI AGDiagnostics2075-44182024-12-011424284110.3390/diagnostics14242841The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes TumoursHande Süer Mickler0Murat Mert Erkan1Graduate School of Health Sciences, Acıbadem Mehmet Ali Aydınlar University, 34752 Istanbul, TurkeyDepartment of Surgery, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, 34752 Istanbul, TurkeyBackground: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- Tyr3-octreotate (DOTATATE) has been employed for SSTR targeting for either diagnostic or therapeutic purposes depending on the labelling with <sup>68</sup>Gallium or <sup>177</sup>Lutetium, respectively. SSTR expression is reported in a subset of breast adenocarcinoma and breast neuroendocrine carcinomas; however, minimal knowledge exists regarding their expression in fibroepithelial (biphasic) breast lesions such as fibroadenoma and phyllodes tumours. Aggressive ends of the spectrum, i.e., “cystosarcoma phyllodes”, may present a management challenge with recurrences and metastases, and SSTRs could be a promising therapeutic target for these types of tumours. Methods: Gene and protein expressions of SSTRs in primary human fibroepithelial lesions of the breast are investigated using RT-PCR and immunoblotting. Localisation of the SSTR-positive cells was determined with immunohistochemistry and immunofluorescence. Results and Conclusions: Both fibroadenoma and phyllodes tumours express SSTRs. Immunohistochemical analyses suggested that this expression is in the stromal, not epithelial, component by demonstrating that SSTR stained in the areas overlapping with α-smooth muscle actin-positive myoepithelial cells around blood vessels and capillary structures. This study is the first in the literature to demonstrate SSTR positivity in mammary fibroepithelial neoplasms. Once validated, these findings may also have significant implications for managing the treatment of these tumours.https://www.mdpi.com/2075-4418/14/24/2841somatostatin receptorsphyllodes tumourfibroadenomabreast fibroepithelial lesionsDOTATATE
spellingShingle Hande Süer Mickler
Murat Mert Erkan
The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
Diagnostics
somatostatin receptors
phyllodes tumour
fibroadenoma
breast fibroepithelial lesions
DOTATATE
title The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
title_full The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
title_fullStr The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
title_full_unstemmed The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
title_short The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
title_sort investigation of somatostatin receptors as a potential target in breast phyllodes tumours
topic somatostatin receptors
phyllodes tumour
fibroadenoma
breast fibroepithelial lesions
DOTATATE
url https://www.mdpi.com/2075-4418/14/24/2841
work_keys_str_mv AT handesuermickler theinvestigationofsomatostatinreceptorsasapotentialtargetinbreastphyllodestumours
AT muratmerterkan theinvestigationofsomatostatinreceptorsasapotentialtargetinbreastphyllodestumours
AT handesuermickler investigationofsomatostatinreceptorsasapotentialtargetinbreastphyllodestumours
AT muratmerterkan investigationofsomatostatinreceptorsasapotentialtargetinbreastphyllodestumours